Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection

Tyrosine kinase inhibitors (TKIs) of aberrant tyrosine kinase (TK) activity have been widely used to treat chronic myeloid leukemia (CML) for decades in clinic. An area of growing interest is the reported ability of TKIs to induce immunomodulatory effects with anti-tumor and anti-viral activity, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Climent, Núria, Plana, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813222/
https://www.ncbi.nlm.nih.gov/pubmed/31680987
http://dx.doi.org/10.3389/fphar.2019.01232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813222/
https://www.ncbi.nlm.nih.gov/pubmed/31680987
http://dx.doi.org/10.3389/fphar.2019.01232

Ejemplares similares